C6H6N2O3
154.12 g/mol
APIWarning
Olbetam
CAS51037-30-0EC256-928-3
Category
API
Compound Class
Heterocycle
Primary Use
Pharmaceutical Raw Material
Acipimox is a niacin derivative used as a pharmaceutical raw material for lipid management. It reduces triglyceride levels and increases HDL cholesterol, and may have less marked adverse effects than niacin.
pharmaceutical raw material for lipid-lowering formulationsresearch compound for lipid metabolism studies
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 51037-30-0
Related Compounds
ReferenceSame Category
(±)-flurbiprofen
CAS5104-49-4
pharmaceutical raw material
ReferenceSame Category
Ergocristine
CAS511-08-0
pharmaceutical raw material
ReferenceSame Category
Somatostatin
CAS51110-01-1
pharmaceutical raw material
ReferenceSame Category
Dexibuprofen
CAS51146-56-6
pharmaceutical raw material
Referencesame scaffold
2-Aminopyrazine 4-oxide
CAS6863-77-0
research compound
Safety Reference
Warning
H319Causes serious eye irritation
Identifiers
IUPAC Name
5-methyl-4-oxidopyrazin-4-ium-2-carboxylic acid
InChIKey
DJQOOSBJCLSSEY-UHFFFAOYSA-N
SMILES
CC1=CN=C(C=[N+]1[O-])C(=O)O
Synonyms (17)
- Acipimox (INN/BAN)
- ACIPIMOX [MART.]
- Acipimox (Standard)
- Acipimox - Bio-X trade mark
- Acipimoxum
- Olbemox
- Olbetam